Tickerplace logo

Tickerplace

Entrada Therapeutics, Inc. logo

TRDAEntrada Therapeutics, Inc.

TRDA Stock Price, Valuation & Chart | Entrada Therapeutics, Inc.

Compare
$7.300+0.23 (+3.25%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyTRDA intrinsic valueTRDA calculated fair value vs price
OverviewFinancialsDividendsRatios

TRDA Historical price chart

TRDA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization283.39M
PE Ratio-1.84
EPS-3.96
Trading Volume306.54K
Today's High/Low7.34/6.97
Dividend Yield0.00
52 Week High/Low16.45/5.02
Shares Outstanding38.82M
TRDA Financial Statement
TRDA Analyst ratings
TRDA Analysis & performance metrics

TRDA Company profile

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal…

TRDA Management team

Management
Nathan J. DowdenCOO
President & Chief Operating Officer
Leo Qian Ph.D.
Co-Founder & Vice President of Discovery Research
Jared Cohen J.D., Ph.D.
General Counsel
Kerry Robert M.S.
Senior Vice President of People
Dipal DoshiCEO
Chief Executive Officer & Director
Murali Mallem
Vice President & Head of CMC
Natarajan Sethuraman Ph.D.
President of Research & Development
Karla MacDonald
Chief Corporate Affairs Officer
Total 8 executives

TRDA Frequently asked questions

What is Entrada Therapeutics, Inc. (TRDA) Stock Price?

Current stock price of Entrada Therapeutics, Inc. (TRDA) stock is $7.300. The stock price is +3.25% higher in the session. The intraday range can be seen from this page. Volume of Entrada Therapeutics, Inc. (TRDA) stock is 306.54K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Entrada Therapeutics, Inc. (TRDA) stock price going up or down today?

The stock price of Entrada Therapeutics, Inc. (TRDA) can change with earnings, company news, and overall market sentiment. Entrada Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Entrada Therapeutics, Inc. stock expensive at its current price?

Whether Entrada Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TRDA on this page is -1.84. EPS on this page is -3.96. Compare those figures with peers and growth expectations before deciding if the current Entrada Therapeutics, Inc. price is justified.

How has the stock price of Entrada Therapeutics, Inc. (TRDA) performed historically?

Historical performance for Entrada Therapeutics, Inc. (TRDA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TRDA reacted to past earnings and market events.

Should I buy Entrada Therapeutics, Inc. (TRDA) stock, at this price?

Buying Entrada Therapeutics, Inc. (TRDA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.